Exchange: NASDAQ·

ITOSITeos Therapeutics Inc

$0.00
$0.00
(0.00%)
Today
Reported EarningsApr 28
Mkt Cap$448.68M
Vol11.01M
50

Neutral Sentiment

How do you feel about ITOS?

News
all
press releases
News Placeholder
iTeos Therapeutics (ITOS) Upgraded to Buy: Here's What You Should Know
Zacks
News Placeholder
iTeos Therapeutics To Wind Down Operations, Explores Asset Sale: Retail Believes It’s ‘Worth More Selling It Off’
The company decided to wind down operations as part of a review of strategic alternatives aimed at maximizing shareholder value after its collaboration with GSK plc ended.
Stocktwits
News Placeholder
GSK Inks $2B Deal With Boston Pharmaceuticals to Buy Liver Disease Drug
Zacks
News Placeholder
iTeos, GSK End Collaboration On Experimental Cancer Therapy Development: But Retail’s Extremely Bullish
The two companies worked together to assess the Belrestotug + Dostarlimab doublet in treating a specific type of lung cancer.
Stocktwits
<
...
1
>

Advertisement|Remove ads.